|
|
Post by yossarian on Mar 20, 2016 22:51:08 GMT -5
Over 67,000,000 shares trades last week All was basically up volume., i.e, the daily high exceeded the previous day's daily high. And only twice since March 1 has the daily low exceeded the previous day's daily low. Think a buyout may be in the works, even with the poison pill in existence.
|
|
|
|
Post by patten1962 on Mar 21, 2016 5:25:01 GMT -5
Over 67,000,000 shares trades last week All was basically up volume., i.e, the daily high exceeded the previous day's daily high. And only twice since March 1 has the daily low exceeded the previous day's daily low. Think a buyout may be in the works, even with the poison pill in existence. I really hope there's not a buyout. I am hoping for Amgen to be a strategic partner in Europe Asia. I am hoping RLS is actually Google life sciences. And I am hoping MannKind goes it alone in the United States. This is the best scenario that we can ask for. I have no proof of this this is just a guess. A want! A dream! |
|
|
|
Post by mindovermatter on Mar 21, 2016 7:22:43 GMT -5
Over 67,000,000 shares trades last week All was basically up volume., i.e, the daily high exceeded the previous day's daily high. And only twice since March 1 has the daily low exceeded the previous day's daily low. Think a buyout may be in the works, even with the poison pill in existence. I really hope there's not a buyout. I am hoping for Amgen to be a strategic partner in Europe Asia. I am hoping RLS is actually Google life sciences. And I am hoping MannKind goes it alone in the United States. This is the best scenario that we can ask for. I have no proof of this this is just a guess. A want! A dream! I doubt that Amgen will be a partner. Pharma execs move all the time. I recall a select bunch kept pushing the narrative that James Shannon going to GlaxoSmithKline meant something good for Mannkind. It didn't. Then he came back to Mannkind and then certain people said that was a good sign. It wasn't. Castagna's move is a move made by many in the industry. He saw an opportunity and took it. But is it possible that AMGEN would want to work Mannkind? Sure. Is it probable? No. |
|
